Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

July 15, 1986; Volume 137,Issue 2

COMMUNICATIONS

  • You have accessRestricted access
    Structural homology between the human 4F2 antigen and a murine cell surface glycoprotein associated with lymphocyte activation.
    C Bron, M Rousseaux, A L Spiazzi and H R MacDonald
    J Immunol July 15, 1986, 137 (2) 397-399;

ARTICLES

  • You have accessRestricted access
    Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    D Santoli, S F Radka, M Igarashi, B L Kreider and S Ferrone
    J Immunol July 15, 1986, 137 (2) 400-407;
  • You have accessRestricted access
    Species-restricted recognition of transfected HLA-A2 and HLA-B7 by human CTL clones.
    S J Mentzer, J A Barbosa, J L Strominger, P A Biro and S J Burakoff
    J Immunol July 15, 1986, 137 (2) 408-413;
  • You have accessRestricted access
    Antigen reactive memory T cells are defined by Ta1.
    D A Hafler, D A Fox, D Benjamin and H L Weiner
    J Immunol July 15, 1986, 137 (2) 414-418;
  • You have accessRestricted access
    Direct stimulation of T lymphocytes by antigen-conjugated beads.
    D W Thomas and M J Solvay
    J Immunol July 15, 1986, 137 (2) 419-421;
  • You have accessRestricted access
    The monoclonal antibodies Trop-4 and 4F2 detect the same membrane antigen that is expressed at an early stage of lymphocyte activation and is retained on secondary lymphocytes.
    H A Suomalainen
    J Immunol July 15, 1986, 137 (2) 422-427;
  • You have accessRestricted access
    Nonspecific suppressor T cells cause decreased mixed lymphocyte culture reactivity in bone marrow transplant patients.
    M Harada, M Ueda, S Nakao, K Kondo, K Odaka, S Shiobara, K Matsue, T Mori and T Matsuda
    J Immunol July 15, 1986, 137 (2) 428-432;
  • You have accessRestricted access
    Suppression of antigraft immunity by preimmunization. III. Characterization of suppressor T cells involved in suppression of the efferent phase of DTH against alloantigens.
    A T Bianchi, L M Hussaarts-Odijk, E A Wolters, A Molendijk and R Benner
    J Immunol July 15, 1986, 137 (2) 433-442;
  • You have accessRestricted access
    Studies on the role of antigen-presenting cells in the systemic suppression of contact hypersensitivity by UVB radiation.
    M L Kripke and E McClendon
    J Immunol July 15, 1986, 137 (2) 443-447;
  • You have accessRestricted access
    A monoclonal antibody specific for a monocyte-macrophage membrane component blocks the human monocyte response to migration inhibitory factor.
    D Y Liu and R F Todd 3rd
    J Immunol July 15, 1986, 137 (2) 448-455;
  • You have accessRestricted access
    Phagocytosis of concanavalin A-treated erythrocytes is mediated by the Fc gamma receptor.
    J E Salmon and R P Kimberly
    J Immunol July 15, 1986, 137 (2) 456-462;
  • You have accessRestricted access
    Purification and target cell range of in vivo elicited blast natural killer cells.
    C A Biron, K F Pedersen and R M Welsh
    J Immunol July 15, 1986, 137 (2) 463-471;
  • You have accessRestricted access
    Partial restoration of the lipopolysaccharide-induced proliferative response in splenic B cells from C3H/HeJ mice.
    K Kuus-Reichel and R J Ulevitch
    J Immunol July 15, 1986, 137 (2) 472-477;
  • You have accessRestricted access
    Changes in phospholipid metabolism during B lymphocyte activation.
    M K Kriz, E S Vitetta and T J Sullivan
    J Immunol July 15, 1986, 137 (2) 478-483;
  • You have accessRestricted access
    Differential expression of ecto-5' nucleotidase activity by functionally and phenotypically distinct subpopulations of human Leu-2+/T8+ lymphocytes.
    U Dianzani, M Massaia, A Pileri, C E Grossi and L T Clement
    J Immunol July 15, 1986, 137 (2) 484-489;
  • You have accessRestricted access
    Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    J A Edwards, B M Durant, D B Jones, P R Evans and J L Smith
    J Immunol July 15, 1986, 137 (2) 490-497;
  • You have accessRestricted access
    Lack of reactivity of rheumatoid arthritis synovial membrane DNA with cloned Epstein Barr virus DNA probes.
    R I Fox, T Chilton, G Rhodes and J H Vaughan
    J Immunol July 15, 1986, 137 (2) 498-501;
  • You have accessRestricted access
    Destruction of autologous human lymphocytes by interleukin 2-activated cytotoxic cells.
    P M Sondel, J A Hank, P C Kohler, B P Chen, D Z Minkoff and J A Molenda
    J Immunol July 15, 1986, 137 (2) 502-511;
  • You have accessRestricted access
    A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues.
    G Zwadlo, R Schlegel and C Sorg
    J Immunol July 15, 1986, 137 (2) 512-518;
  • You have accessRestricted access
    All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma.
    T A Gonwa, J P Frost and R W Karr
    J Immunol July 15, 1986, 137 (2) 519-524;
  • You have accessRestricted access
    Enhancement of glomerular mesangial cell neutral proteinase secretion by macrophages: role of interleukin 1.
    J Martin, D H Lovett, D Gemsa, R B Sterzel and M Davies
    J Immunol July 15, 1986, 137 (2) 525-529;
  • You have accessRestricted access
    Evaluation of sequential glomerular eluates from rats with Heymann nephritis.
    C K Abrass
    J Immunol July 15, 1986, 137 (2) 530-535;
  • You have accessRestricted access
    Polymeric IgA rheumatoid factor in idiopathic IgA mesangial nephropathy (Berger's disease).
    R A Sinico, A Fornasieri, N Oreni, S Benuzzi and G D'Amico
    J Immunol July 15, 1986, 137 (2) 536-541;
  • You have accessRestricted access
    Materno-embryonally transferred antibodies precipitate autoimmune thyroiditis in obese strain (OS) chickens.
    D V Katz, B Albini and J H Kite Jr
    J Immunol July 15, 1986, 137 (2) 542-545;
  • You have accessRestricted access
    Characterization of antigen-specific T cells in multiple sclerosis twins with elevated proliferative responses to measles virus.
    J I Greenstein, H F McFarland and J R Richert
    J Immunol July 15, 1986, 137 (2) 546-550;
  • You have accessRestricted access
    Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells).
    F Shirakawa, Y Tanaka, S Eto, H Suzuki, J Yodoi and U Yamashita
    J Immunol July 15, 1986, 137 (2) 551-556;
  • You have accessRestricted access
    Evidence for shared antigenic determinants on rabbit and human interleukin 1 (IL 1).
    P L Simon and J C Lee
    J Immunol July 15, 1986, 137 (2) 557-562;
  • You have accessRestricted access
    Interleukin 3 (IL 3) regulates the in vitro proliferation of both blood monocytes and peritoneal exudate macrophages: synergism between a macrophage lineage-specific colony-stimulating factor (CSF-1) and IL 3.
    B D Chen and C R Clark
    J Immunol July 15, 1986, 137 (2) 563-570;
  • You have accessRestricted access
    Identification of a human monocyte cytotoxicity-inducing factor from T cell hybridomas produced from Sezary's cells.
    C M Jones, C A Prince, M P Langford and J P Hester
    J Immunol July 15, 1986, 137 (2) 571-577;
  • You have accessRestricted access
    T cell replacing factor for steroids (TRF-S): a 40,000 dalton protein produced by a T4+ T cell.
    F M Orson, F P Flagge and J L Cashaw
    J Immunol July 15, 1986, 137 (2) 578-584;
  • You have accessRestricted access
    A suppressive lymphokine of platelet cytotoxic functions.
    V Pancré, C Auriault, M Joseph, J Y Cesbron, J P Kusnierz and A Capron
    J Immunol July 15, 1986, 137 (2) 585-591;
  • You have accessRestricted access
    Antigen-specific murine T cell clones produce soluble interleukin 2 receptor on stimulation with specific antigens.
    D K Wagner, J York-Jolley, T R Malek, J A Berzofsky and D L Nelson
    J Immunol July 15, 1986, 137 (2) 592-596;
  • You have accessRestricted access
    Production of idiotypic and anti-idiotypic antibodies by BALB/c mice in response to immunizations with glucagon, vasopressin, or insulin: supporting evidence for the network concept.
    T M Reilly and R T Root
    J Immunol July 15, 1986, 137 (2) 597-602;
  • You have accessRestricted access
    Regulation of the BALB/c anti-p-azophenylarsonate antibody response by monoclonal anti-idiotype. I. Anti-idiotope fine specificity.
    A R Brown and R E Sealy
    J Immunol July 15, 1986, 137 (2) 603-609;
  • You have accessRestricted access
    Regulation of the BALB/c anti-p-azophenylarsonate antibody response by monoclonal anti-idiotype. II. Idiotope expression in serum and its regulation.
    A R Brown and R E Sealy
    J Immunol July 15, 1986, 137 (2) 610-617;
  • You have accessRestricted access
    Production and characterization of a murine monoclonal IgM antibody to human C1q receptor (C1qR).
    B Ghebrehiwet
    J Immunol July 15, 1986, 137 (2) 618-624;
  • You have accessRestricted access
    Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
    A J Tenner and M M Frank
    J Immunol July 15, 1986, 137 (2) 625-630;
  • You have accessRestricted access
    C1s-induced vascular permeability in C2-deficient guinea pigs.
    C J Strang, H S Auerbach and F S Rosen
    J Immunol July 15, 1986, 137 (2) 631-635;
  • You have accessRestricted access
    Aberrant activation and regulation of the oxidative burst in neutrophils with Mol glycoprotein deficiency.
    W M Nauseef, P De Alarcon, J F Bale and R A Clark
    J Immunol July 15, 1986, 137 (2) 636-642;
  • You have accessRestricted access
    Enhancement of the expression of a rat neutrophil-specific cell surface antigen by activation with phorbol myristate acetate and concanavalin A.
    S Gotoh, M Itoh, Y Fujii, S Arai and F Sendo
    J Immunol July 15, 1986, 137 (2) 643-650;
  • You have accessRestricted access
    Down-regulation of macrophage lysozyme by lipopolysaccharide and interferon.
    A H Warfel and D Zucker-Franklin
    J Immunol July 15, 1986, 137 (2) 651-655;
  • You have accessRestricted access
    Histamine H2-receptor-mediated regulation of human natural killer cell activity.
    K Hellstrand and S Hermodsson
    J Immunol July 15, 1986, 137 (2) 656-660;
  • You have accessRestricted access
    In vitro locomotion of allosensitized T lymphocyte clones in response to metabolites of arachidonic acid is subset specific.
    M L Jordan, R A Hoffman, E F Debe and R L Simmons
    J Immunol July 15, 1986, 137 (2) 661-668;
  • You have accessRestricted access
    Reactivity of E. coli-derived trans-activating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficiency syndrome.
    A D Barone, J J Silva, D D Ho, R C Gallo, F F Wong-Staal and N T Chang
    J Immunol July 15, 1986, 137 (2) 669-673;
  • You have accessRestricted access
    Human retroviral env and gag polypeptides: serologic assays to measure infection.
    S B Kanner, C Cheng-Mayer, R B Geffin, W P Parks, G A Beltz, L O Arthur, K P Samuel and T S Papas
    J Immunol July 15, 1986, 137 (2) 674-678;
  • You have accessRestricted access
    Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts.
    K L Holmes, W Y Langdon, T N Fredrickson, R L Coffman, P M Hoffman, J W Hartley and H C Morse 3rd
    J Immunol July 15, 1986, 137 (2) 679-688;
  • You have accessRestricted access
    Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages.
    C D Rothermel, B Y Rubin, E A Jaffe and H W Murray
    J Immunol July 15, 1986, 137 (2) 689-692;
  • You have accessRestricted access
    Macrophage-mediated fungistasis: requirement for a macromolecular component in serum.
    D L Granger, J R Perfect and D T Durack
    J Immunol July 15, 1986, 137 (2) 693-701;
  • You have accessRestricted access
    Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    W Solbach, K Forberg, E Kammerer, C Bogdan and M Röllinghoff
    J Immunol July 15, 1986, 137 (2) 702-707;
  • You have accessRestricted access
    Anti-Ig induces release of inositol 1,4,5-trisphosphate, which mediates mobilization of intracellular Ca++ stores in B lymphocytes.
    J T Ransom, L K Harris and J C Cambier
    J Immunol July 15, 1986, 137 (2) 708-714;
  • You have accessRestricted access
    Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.
    J C Yang, J J Mulé and S A Rosenberg
    J Immunol July 15, 1986, 137 (2) 715-722;
  • You have accessRestricted access
    K562 killing by K, IL 2-responsive NK, and T cells involves different effector cell post-binding trigger mechanisms.
    F Shanahan, M D Brogan, W Newman and S R Targan
    J Immunol July 15, 1986, 137 (2) 723-726;
  • You have accessRestricted access
    Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
    J M Fidler, S Q DeJoy and J J Gibbons Jr
    J Immunol July 15, 1986, 137 (2) 727-732;
  • You have accessRestricted access
    Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
    K Ohnishi and B Bonavida
    J Immunol July 15, 1986, 137 (2) 733-740;
  • You have accessRestricted access
    Properties of a panel of monoclonal antibodies which react with the human T cell antigen receptor on the leukemic line HPB-ALL and a subset of normal peripheral blood T lymphocytes.
    A W Boylston, J Borst, H Yssel, D Blanchard, H Spits and J E de Vries
    J Immunol July 15, 1986, 137 (2) 741-744;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 137, Issue 2
15 Jul 1986
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • COMMUNICATIONS
  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606